CXCR6 and post-transplant lymphoproliferative disease: While a genome-wide association study identified a positive correlation between LCL CXCL16 expression and EBV copy number (42), it is not known if CXCR6 is required for the effective trafficking of VST to EBV PTLD tumor sites.